Jorge E Gomez

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Smoking Cessation

Respiratory Syndrome Coronavirus

Liver Metastases

Ejection Fraction

Top Venues

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, Jorge E Gomez, Jazz Cagan, Yuanhui Huang, Sooyun Caroline Tavolacci, Rajesh M Valanparambil, Nicholas Rohs, Rachel Brody, Brittney Nichols, Juan Manuel Carreño, Sheena Bhalla, Christian Rolfo, David E Gerber, Amy Moore, Jennifer C King, Rafi Ahmed, John D Minna, Paul A Bunn, Adolfo García-Sastre, Florian Krammer, Fred R Hirsch, Yu Shyr
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer. Vaccines 12 (7) (2024)
Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, Jorge E Gomez, Jazz Cagan, Yuanhui Huang, Sooyun Caroline Tavolacci, Rajesh M Valanparambil, Nicholas Rohs, Rachel Brody, Brittney Nichols, Juan Manuel Carreño, Sheena Bhalla, Christian Rolfo, David E Gerber, Amy Moore, Jennifer C King, Rafi Ahmed, John D Minna, Paul A Bunn, Adolfo García-Sastre, Florian Krammer, Fred R Hirsch, Yu Shyr
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer. Vaccines 12 (7) (2024)
Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, Jorge E Gomez, Jazz Cagan, Yuanhui Huang, Sooyun Caroline Tavolacci, Rajesh M Valanparambil, Nicholas Rohs, Rachel Brody, Brittney Nichols, Juan Manuel Carreño, Sheena Bhalla, Christian Rolfo, David E Gerber, Amy Moore, Jennifer C King, Rafi Ahmed, John D Minna, Paul A Bunn, Adolfo García-Sastre, Florian Krammer, Fred R Hirsch, Yu Shyr
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer. Vaccines 12 (7) (2024)
Byoung Chul Cho, Dong Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura, Sang-We Kim, Rachel E Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna R Minchom, Jong-Seok Lee, Ji-Youn Han, Misako Nagasaka, Joshua K Sabari, Sai-Hong Ignatius Ou, Patricia Lorenzini, Joshua M Bauml, Joshua C Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E Knoblauch, Keunchil Park
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial. Nature medicine (2023)
Priyanka Jain, Kellie Ryan, Maral DerSarkissian, Akanksha Dua, Christopher Yee, Mei Sheng Duh, Jorge E Gomez
Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer. PloS one 15 (3) (2020)